在直接压缩中共同加工的辅助剂的功能属性
Renate Coetzee1, Josias Hamman1, Jan Steenekamp1
1Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.
Pharmaceutical development and technology
|November 5, 2025
概括
同处理的辅助剂通过优化粉末的特性,如流量和可压缩性来增强药片制造. 本综述探讨了与传统辅助剂相比,它们的制备,功能和在克服配方挑战方面的有效性.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 化学工程是化学工程的重要组成部分.
背景情况:
- 传统的辅助剂在优化药片制造工艺方面存在局限性.
- 协同处理提供了一种策略,以提高粉末的关键性质,以实现高效的药片生产,特别是通过直接压缩.
研究的目的:
- 审查共同加工的辅助剂的制备方法.
- 讨论联合加工的辅助剂在药片配方和制造中比传统辅助剂的优势.
- 评估它们在分子,粒子和散装层面的性能提升.
主要方法:
- 对联合加工辅助剂制备技术的文献综述.
- 在不同材料层面 (分子,粒子,散装) 分析功能性益处.
- 在应对特定的制定挑战时的绩效评估.
主要成果:
- 同处理的辅助剂显示出改善的流动性,压缩性和紧缩性.
- 增强的功能带来了提高平板电脑制造效率和一致性.
- 在减轻诸如湿度敏感性,滑剂敏感性和延展率敏感性等问题的有效性.
结论:
- 联合加工的辅助剂比平板制造的常规辅助剂具有显著的进步.
- 它们的定制性质为常见的配方和加工挑战提供了解决方案.
- 尽管存在监管方面的考虑,但预计将进一步采用.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
390
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
390
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
296
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
296
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
164
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
164
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
142
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
142
Factors Influencing Drug Absorption: Physicochemical Parameters
805
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
805
Drug Dissolution: Requirements and Profile Comparison
224
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
224


